• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    Raptor Pharmaceuticals Corp. (RPTP)

    -NasdaqGM
    5.38 Up 0.33(6.53%) May 27, 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 94,240   69,497   16,872  
    Cost of Revenue12,621  9,416  1,653  
    Gross Profit 81,619   60,081   15,219  
    Operating Expenses
    Research Development58,634  43,477  29,177  
    Selling General and Administrative71,443  56,654  37,948  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (48,458) (40,050) (51,906)
    Income from Continuing Operations
    Total Other Income/Expenses Net(527)1,535  (10,679)
    Earnings Before Interest And Taxes(48,985)(38,515)(62,585)
    Interest Expense15,793  13,971  6,832  
    Income Before Tax(64,778)(52,486)(69,417)
    Income Tax Expense444  54   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(65,222)(52,540)(69,417)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (65,222) (52,540) (69,417)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (65,222) (52,540) (69,417)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.